Ipamorelin
Typical Dosage
100-300 mcg
Administration
Injection
Half-Life
~2 hours
Mechanism of Action
Selective GH release research|Sleep/recovery studies|IGF-1 modulation|Combination peptide protocols
Research Protocol Summary
Evidence Level
Early Human / Investigational
Typical Protocol Duration
6-12 weeks
Species Studied
Human • Rat
Administration Schedule
2-3 times daily, fasted
Timing Notes
PM fasted state
Studies
Research Availability
Individual PubMed records have not been mapped for this entry yet. Use the linked PubMed search to review the current literature directly.
Related resources
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Loading approved insights…